Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

The proof of the pudding: in praise of a culture of real-world validation for medical artificial intelligence.

Cabitza F, Zeitoun JD.

Ann Transl Med. 2019 Apr;7(8):161. doi: 10.21037/atm.2019.04.07. No abstract available.

2.

Comparison of 20-gauge Procore® and 22-gauge Acquire® needles for EUS-FNB of solid pancreatic masses: an observational study.

Karsenti D, Tharsis G, Zeitoun JD, Denis P, Perrot B, Coelho J, Bellaiche G, Charbit L, Hakoune JJ, Doumet S, Sion-Rohart E, Cavicchi M, Zago J.

Scand J Gastroenterol. 2019 Apr;54(4):499-505. doi: 10.1080/00365521.2019.1599418. Epub 2019 May 8.

PMID:
31067140
3.

[Sentinel node and breast cancer: A state-of-the-art in 2019].

Zeitoun J, Babin G, Lebrun JF.

Gynecol Obstet Fertil Senol. 2019 Jun;47(6):522-526. doi: 10.1016/j.gofs.2019.04.002. Epub 2019 Apr 5. French.

PMID:
30959186
4.

Online training on how to diagnose anoperineal lesions of Crohn's disease: Do pictures matter? A nationwide randomized study.

Geffrier C, de Parades V, Abramowitz L, Benfredj P, Bonnaud G, Bord C, Bouchard D, Bouguen G, Devulder F, Didelot JM, Fathallah N, Higuero T, Lesage X, Nouts A, Petit P, Pigot F, Pommaret E, Roumeguere P, Siproudhis L, Staumont G, Zeitoun JD, Marteau P.

Clin Res Hepatol Gastroenterol. 2019 Aug;43(4):483-496. doi: 10.1016/j.clinre.2018.12.003. Epub 2019 Mar 29.

PMID:
30935906
5.

MR imaging of cystic ovarian teratoma with internal floating globules.

Zeitoun J, Escalard C, Benoist G.

Diagn Interv Imaging. 2018 Nov;99(11):725-726. doi: 10.1016/j.diii.2018.08.005. Epub 2018 Sep 13. No abstract available.

PMID:
30220586
6.

Long-term Outcome of a Fissurectomy: A Prospective Single-Arm Study of 50 Operations out of 349 Initial Patients.

Zeitoun JD, Blanchard P, Fathallah N, Benfredj P, Lemarchand N, de Parades V.

Ann Coloproctol. 2018 Apr;34(2):83-87. doi: 10.3393/ac.2017.06.12. Epub 2018 Apr 30.

7.

Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis.

Zeitoun JD, Ross JS, Atal I, Vivot A, Downing NS, Baron G, Ravaud P.

Clin Pharmacol Ther. 2018 Nov;104(5):1000-1007. doi: 10.1002/cpt.1038. Epub 2018 Feb 24.

PMID:
29377075
8.

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.

Zeitoun JD, Ross JS, Atal I, Vivot A, Downing NS, Baron G, Ravaud P.

BMJ Open. 2017 Dec 21;7(12):e018587. doi: 10.1136/bmjopen-2017-018587.

9.

High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn's Disease.

Beaugerie L, Carrat F, Nahon S, Zeitoun JD, Sabaté JM, Peyrin-Biroulet L, Colombel JF, Allez M, Fléjou JF, Kirchgesner J, Svrcek M; Cancers et Surrisque Associé aux Maladies Inflammatoires Intestinales En France Study Group.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):892-899.e2. doi: 10.1016/j.cgh.2017.11.041. Epub 2017 Dec 2.

PMID:
29199142
10.

Tibial tubercle torsion, a new factor of patellar instability.

Chassaing V, Zeitoun JM, Camara M, Blin JL, Marque S, Chancelier MD.

Orthop Traumatol Surg Res. 2017 Dec;103(8):1173-1178. doi: 10.1016/j.otsr.2017.07.019. Epub 2017 Sep 21.

11.

Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.

Zeitoun JD, Baron G, Vivot A, Atal I, Downing NS, Ross JS, Ravaud P.

Int J Cancer. 2018 Jan 15;142(2):414-423. doi: 10.1002/ijc.31061. Epub 2017 Oct 12.

12.

Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.

Bouchard D, Abramowitz L, Bouguen G, Brochard C, Dabadie A, de Parades V, Eléouet-Kaplan M, Fathallah N, Faucheron JL, Maggiori L, Panis Y, Pigot F, Rouméguère P, Sénéjoux A, Siproudhis L, Staumont G, Suduca JM, Vinson-Bonnet B, Zeitoun JD.

Tech Coloproctol. 2017 Sep;21(9):683-691. doi: 10.1007/s10151-017-1684-y. Epub 2017 Sep 19. Review.

13.

Contralateral Bias of High Spatial Frequency Tuning and Cardinal Direction Selectivity in Mouse Visual Cortex.

Salinas KJ, Figueroa Velez DX, Zeitoun JH, Kim H, Gandhi SP.

J Neurosci. 2017 Oct 18;37(42):10125-10138. doi: 10.1523/JNEUROSCI.1484-17.2017. Epub 2017 Sep 18.

14.

Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing.

Vivot A, Boutron I, Béraud-Chaulet G, Zeitoun JD, Ravaud P, Porcher R.

Sci Rep. 2017 Jul 31;7(1):6882. doi: 10.1038/s41598-017-07358-7.

15.

Impact of resident and fellow changeovers on patient outcomes: a nationwide cross-sectional study.

Zeitoun JD, Reboul-Marty J, Lefèvre JH.

Eur J Public Health. 2017 Dec 1;27(6):960-965. doi: 10.1093/eurpub/ckx072.

PMID:
28549099
16.

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010.

Downing NS, Shah ND, Aminawung JA, Pease AM, Zeitoun JD, Krumholz HM, Ross JS.

JAMA. 2017 May 9;317(18):1854-1863. doi: 10.1001/jama.2017.5150.

17.

Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015.

Vivot A, Jacot J, Zeitoun JD, Ravaud P, Crequit P, Porcher R.

Ann Oncol. 2017 May 1;28(5):1111-1116. doi: 10.1093/annonc/mdx053.

18.

Readmissions After Surgery: A French Nationwide Cross-Sectional Study of 1,686,602 Procedures Performed in 2010.

Lefèvre JH, Reboul-Marty J, de Vaugrigneuse S, Zeitoun JD.

World J Surg. 2017 Jan;41(1):31-38. doi: 10.1007/s00268-016-3740-6.

PMID:
27718005
19.

Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries.

Atal I, Zeitoun JD, Névéol A, Ravaud P, Porcher R, Trinquart L.

BMC Bioinformatics. 2016 Sep 22;17(1):392.

20.

Diabetes Self-Management Education in the Home.

Lavelle D, Zeitoun J, Stern M, Butkiewicz E, Wegner E, Reinisch C.

Cureus. 2016 Jul 25;8(7):e710. doi: 10.7759/cureus.710.

21.

Emergency surgery for epidural abcess secondary to sacral fistula after laparoscopic proctectomy.

Zeitoun J, Menahem B, Fohlen A, Lebreton G, Lubrano J, Alves A.

J Surg Case Rep. 2016 Jul 15;2016(7). pii: rjw108. doi: 10.1093/jscr/rjw108.

22.

Brain injury unmasking Ehlers-Danlos syndromes after trauma: the fiber print.

Hamonet C, Frédy D, Lefèvre JH, Bourgeois-Gironde S, Zeitoun JD.

Orphanet J Rare Dis. 2016 Apr 22;11:45. doi: 10.1186/s13023-016-0428-9.

23.

[The challenge of digital technologies in healthcare]

Zeitoun JD, H Lefèvre J.

Rev Prat. 2016 Jan;66(1):25-29. French.

PMID:
30512393
24.

Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov.

Vivot A, Li J, Zeitoun JD, Mourah S, Crequit P, Ravaud P, Porcher R.

Genet Med. 2016 Aug;18(8):796-805. doi: 10.1038/gim.2015.165. Epub 2015 Dec 17.

PMID:
26681315
25.

Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.

Zeitoun JD, Lefèvre JH, Downing NS, Bergeron H, Ross JS.

Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):687-94. doi: 10.1002/pds.3910. Epub 2015 Nov 11.

PMID:
26554874
26.

Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.

Zeitoun JD, Lefèvre JH, Downing NS, Bergeron H, Ross JS.

Br J Clin Pharmacol. 2015 Oct;80(4):716-26. doi: 10.1111/bcp.12643. Epub 2015 May 28.

27.

Inconsistencies among European Union pharmaceutical regulator safety communications: a cross-country comparison.

Zeitoun JD, Lefèvre JH, Downing N, Bergeron H, Ross JS.

PLoS One. 2014 Oct 21;9(10):e109100. doi: 10.1371/journal.pone.0109100. eCollection 2014.

28.

Functional digestive symptoms and quality of life in patients with Ehlers-Danlos syndromes: results of a national cohort study on 134 patients.

Zeitoun JD, Lefèvre JH, de Parades V, Séjourné C, Sobhani I, Coffin B, Hamonet C.

PLoS One. 2013 Nov 22;8(11):e80321. doi: 10.1371/journal.pone.0080321. eCollection 2013.

29.

[Chronic constipation in adults].

Zeitoun JD, de Parades V.

Presse Med. 2013 Sep;42(9 Pt 1):1176-85. doi: 10.1016/j.lpm.2012.09.034. Epub 2013 Mar 1. French.

PMID:
23453994
30.

Infliximab infusion time in patients with inflammatory bowel diseases: is longer really safer?

Belhassan M, Zeitoun JD, Lefevre JH, Charachon A, Amiot A, Le Baleur Y, Sobhani I, Delchier JC.

Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):189-92. doi: 10.1016/j.clinre.2012.07.004. Epub 2012 Dec 12.

PMID:
23246140
31.

[Anal intraepithelial neoplasia].

de Parades V, Fathallah N, Barret M, Zeitoun JD, Lemarchand N, Molinié V, Weiss L.

Presse Med. 2013 Jul-Aug;42(7-8):1091-9. doi: 10.1016/j.lpm.2012.07.037. Epub 2012 Oct 31. French.

PMID:
23122632
32.

Synchronous perianal metastasis of lung adenocarcinoma: report of a case.

Camus M, de Parades V, Fléjou JF, Atienza P, Zeitoun JD.

Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):e143-4. doi: 10.1016/j.clinre.2012.07.012. Epub 2012 Sep 5. No abstract available.

PMID:
22959092
33.

[Communication of scientific fraud].

Zeitoun JD, Rouquette S.

Presse Med. 2012 Sep;41(9 Pt 1):872-7. doi: 10.1016/j.lpm.2012.05.002. Epub 2012 Jun 28. French.

PMID:
22748859
34.

Horseshoe tract of anal fistula: bad luck or an avoidable extension? Lessons from 82 cases.

de Parades V, Fathallah N, Blanchard P, Zeitoun JD, Bennadji B, Atienza P.

Colorectal Dis. 2012 Dec;14(12):1512-5. doi: 10.1111/j.1463-1318.2012.03034.x.

PMID:
22443225
35.

Epidemiology and adherence to guidelines on the management of bleeding peptic ulcer: a prospective multicenter observational study in 1140 patients.

Zeitoun JD, Rosa-Hézode I, Chryssostalis A, Nalet B, Bour B, Arpurt JP, Denis J, Nahon S, Pariente A, Hagège H; Groupe des Hémorragies Digestives Hautes de l’ANGH.

Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):227-34. doi: 10.1016/j.clinre.2011.11.008. Epub 2012 Feb 3.

PMID:
22306054
36.

[A brief history of treatment of haemorrhoids: from ancient Egypt to modern times...].

de Parades V, Zeitoun JD, Atienza P, Parisot C, Parnaud E.

Presse Med. 2011 Oct;40(10):960-5. doi: 10.1016/j.lpm.2011.06.008. Epub 2011 Aug 6. French. No abstract available.

PMID:
21821387
37.

[Haemorrhoidal disease: from pathophysiology to clinical presentation].

Zeitoun JD, de Parades V.

Presse Med. 2011 Oct;40(10):920-6. doi: 10.1016/j.lpm.2011.06.017. Epub 2011 Aug 6. French.

PMID:
21821386
38.

[Management of haemorrhoidal disease].

Zeitoun JD, de Parades V.

Presse Med. 2011 Oct;40(10):948-54. doi: 10.1016/j.lpm.2011.06.010. Epub 2011 Aug 6. French.

PMID:
21821385
39.

[Why a special issue on haemorrhoidal disease?].

Zeitoun JD, de Parades V.

Presse Med. 2011 Oct;40(10):918-9. doi: 10.1016/j.lpm.2011.06.016. Epub 2011 Aug 6. French. No abstract available.

PMID:
21821382
40.

[Resurfacing of a trochanteric pressure sore by a pedicled fasciocutaneous anterolateral thigh flap: a case report].

Zeitoun J, Faghahati S, Burin Des Roziers B, Daoud G, Cartier S.

Ann Chir Plast Esthet. 2013 Jun;58(3):255-8. doi: 10.1016/j.anplas.2010.09.012. Epub 2010 Oct 27. French.

PMID:
21030131
41.

Cryptoglandular anal fistula.

de Parades V, Zeitoun JD, Atienza P.

J Visc Surg. 2010 Aug;147(4):e203-15. doi: 10.1016/j.jviscsurg.2010.07.007. Epub 2010 Sep 6. Review.

PMID:
20822966
42.

Endorectal advancement flap with muscular plication: a modified technique for rectovaginal fistula repair.

de Parades V, Dahmani Z, Blanchard P, Zeitoun JD, Sultan S, Atienza P.

Colorectal Dis. 2011 Aug;13(8):921-5. doi: 10.1111/j.1463-1318.2010.02338.x. Epub 2010 May 28.

PMID:
20528893
43.

[Anal fistula].

de Parades V, Zeitoun JD, Dahmani Z, Parnaud E.

Gastroenterol Clin Biol. 2010 Jan;34(1):48-60. doi: 10.1016/j.gcb.2009.10.014. Epub 2009 Dec 8. Review. French. No abstract available.

44.

You cannot see the wood for the tree.

Dhooge M, Zeitoun JD, Tayar C, Kobeiter H, Lesprit P, Delchier JC, Charachon A.

Am J Gastroenterol. 2009 Oct;104(10):2636-7. doi: 10.1038/ajg.2009.323. No abstract available.

PMID:
19806103
45.

Self-expanding metallic stent for ischemic colonic obstruction.

Zeitoun JD, Van Nhieu JT, Brunetti F, Luciani A, Karoui M, Delchier JC, Charachon A.

Am J Gastroenterol. 2009 Sep;104(9):2372-3. doi: 10.1038/ajg.2009.309. No abstract available.

PMID:
19727109
46.

[The future of gastrointestinal surgery in France: national survey of 929 medical students and results of professional choices after the 2008 national ranking exam].

Maggiori L, Brouquet A, Zeitoun JD, Roupret M, Lefevre JH.

J Chir (Paris). 2009 Apr;146(2):168-74. doi: 10.1016/j.jchir.2009.05.002. Epub 2009 Jun 11. French.

PMID:
19523630
47.

Anal ulceration in a young man.

Zeitoun JD, Kaci R, Homsi T, Hermine O, de Parades V.

Gut. 2009 Mar;58(3):403, 430. doi: 10.1136/gut.2008.152504. No abstract available.

PMID:
19211855
48.

Seton drainage and fibrin glue injection for complex anal fistulas.

de Parades V, Far HS, Etienney I, Zeitoun JD, Atienza P, Bauer P.

Colorectal Dis. 2010 May;12(5):459-63. doi: 10.1111/j.1463-1318.2009.01811.x. Epub 2009 Feb 7.

PMID:
19210300
49.

[Cryptoglandular anal fistulas].

de Parades V, Zeitoun JD, Bauer P, Atienza P.

Rev Prat. 2008 Oct 31;58(16):1775-82. French.

PMID:
19143149
50.

Computed virtual chromoendoscopy system (FICE): a new tool for upper endoscopy?

Coriat R, Chryssostalis A, Zeitoun JD, Deyra J, Gaudric M, Prat F, Chaussade S.

Gastroenterol Clin Biol. 2008 Apr;32(4):363-9. doi: 10.1016/j.gcb.2007.11.013. Epub 2008 Mar 19.

Supplemental Content

Loading ...
Support Center